Previous 10 | Next 10 |
Masimo PSi, a Processed EEG Parameter, “Better Captured” Changes in Brain State Compared to Other Assessment Methods Masimo (NASDAQ: MASI) today announced the findings of a study published in Frontiers in Neuroscience in which Dr. Lichy Han and colleagues at Stanfo...
ATLANTA, July 25, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) complied with federal securities laws. On July 17, 2023, the Company announced preliminary revenue re...
2023-07-22 10:45:00 ET Summary Ensemble Capital Management, LLC is based in Burlingame, California, midway between Silicon Valley and San Francisco. The firm offers customized portfolio management and philanthropic solutions with unparalleled client service. Despite not owning man...
NEW YORK, NY / ACCESSWIRE / July 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Masimo Corporation ("Masimo" or "the Company") (NASDAQ:MASI). Investors who purchased Masimo securities are encouraged to obtain additional information ...
2023-07-19 12:46:15 ET Stifel has lowered its rating of Masimo Corp. ( NASDAQ: MASI ) to hold in the wake of the medical technology and audio equipment maker's disappointing preliminary Q2 results and adjusted guidance. The investment bank said that while Masimo's long-term heal...
2023-07-18 13:34:49 ET Shares of Masimo (NASDAQ: MASI) were down by 18.5% as of 1:30 p.m. on Tuesday. The patient monitoring company announced preliminary numbers for the second quarter after the markets closed on Monday. The stock is now down by about 19% so far this year. Masi...
2023-07-18 10:13:56 ET Gainers: iCAD ( ICAD ) +31% . Biophytis ( BPTS ) +27% . Hyperfine ( HYPR ) +15% . Cabaletta Bio ( VERU ) +12% . Mind Medicine (MindMed) ( MNMD ) +10% . Losers: Lixte Biotechnology ( LIXT ) ...
2023-07-17 18:09:12 ET Masimo ( NASDAQ: MASI ) stock plunged 25% in after-hours trading Monday after the medtech provider reported lower-than-expected preliminary revenue for Q2 and disclosed it would be cutting costs in the latter half of the year. Masimo said that it now sees ...
Management to announce and discuss complete second quarter 2023 financial results on Tuesday, August 8, 2023. Masimo Corporation (Nasdaq: MASI) today announced preliminary revenue results for the second quarter ended July 1, 2023. This press release features multimedia. View the ful...
Appreciates Support From Fellow Shareholders Demonstrating Clear Mandate For Change Nominees Michelle Brennan and Quentin Koffey Are Ready to Work Constructively in the Masimo Boardroom to Benefit All Stakeholders Politan Capital Management (together with its affiliates, “...
News, Short Squeeze, Breakout and More Instantly...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) will release second quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, August 6, 2024. The conference call to review the results will begin at 1...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...